Background and purpose: Temporal distributions in PSA levels following therapeutic intervention for prostate cancer are known to contain characteristics prognostic of disease progression. An algorithm was developed for extracting such characteristics, specifically in the context of previous observations following radiotherapy. Material and methods: Segmented regression methods were investigated for characterising the ‘signatures’ in log(PSA) descent patterns between intervention and nadir. Results: The segmented regression method can automatically identify and parameterise features in a PSA distribution including failure points and doubling time patterns following nadir. The method has previously been applied to the analysis of descent patt...
Prostate-specific antigens (PSA) help monitor the post-therapy course of prostate cancer. If radioth...
Abstract: Patient reported outcome measures (PROMs) are increasingly being used in research to explo...
BackgroundFor men on active surveillance for prostate cancer, utility of prostate-specific antigen (...
Background: We sought to determine whether inter-patient variations in pattern of PSA changes after ...
International audienceProstate-specific antigen (PSA) is a biomarker routinely and repeatedly measur...
Prostate Specific Antigen (PSA) is a biochemical marker used to monitor prostate cancer following tr...
International audiencePURPOSE: To assess the relationship between prognostic factors, postradiation ...
External beam radiation therapy is a widespread treatment for prostate cancer. The ensuing patient f...
Background and purpose: Biochemical recurrence after prostatectomy is commonly treated with salvage ...
Dataset and scripts to analyze and predict PSA dynamics after external radiotherapy of prostate canc...
PURPOSE: The CHHiP trial assessed moderately hypofractionated radiation therapy in localized prostat...
For monitoring patients treated for prostate cancer, Prostate Specific Antigen (PSA) is measured per...
Prostate cancer is the most prevalent form of cancer and the second most common cause of cancer deat...
This thesis aims to develop and validate dynamic predictive joint models (JMs) to characterise the p...
AbstractIntroductionThe dynamics of prostate specific antigen (PSA) in patients who have prostate ca...
Prostate-specific antigens (PSA) help monitor the post-therapy course of prostate cancer. If radioth...
Abstract: Patient reported outcome measures (PROMs) are increasingly being used in research to explo...
BackgroundFor men on active surveillance for prostate cancer, utility of prostate-specific antigen (...
Background: We sought to determine whether inter-patient variations in pattern of PSA changes after ...
International audienceProstate-specific antigen (PSA) is a biomarker routinely and repeatedly measur...
Prostate Specific Antigen (PSA) is a biochemical marker used to monitor prostate cancer following tr...
International audiencePURPOSE: To assess the relationship between prognostic factors, postradiation ...
External beam radiation therapy is a widespread treatment for prostate cancer. The ensuing patient f...
Background and purpose: Biochemical recurrence after prostatectomy is commonly treated with salvage ...
Dataset and scripts to analyze and predict PSA dynamics after external radiotherapy of prostate canc...
PURPOSE: The CHHiP trial assessed moderately hypofractionated radiation therapy in localized prostat...
For monitoring patients treated for prostate cancer, Prostate Specific Antigen (PSA) is measured per...
Prostate cancer is the most prevalent form of cancer and the second most common cause of cancer deat...
This thesis aims to develop and validate dynamic predictive joint models (JMs) to characterise the p...
AbstractIntroductionThe dynamics of prostate specific antigen (PSA) in patients who have prostate ca...
Prostate-specific antigens (PSA) help monitor the post-therapy course of prostate cancer. If radioth...
Abstract: Patient reported outcome measures (PROMs) are increasingly being used in research to explo...
BackgroundFor men on active surveillance for prostate cancer, utility of prostate-specific antigen (...